News

Phase III Clinical Trial TIGeR-PaC Continues to Enroll with the Goals to Extend Survival and Improve Quality of Life for Pancreatic Cancer Patients Los Altos, CA, July 8, 2021 –…

CHARLOTTE, N.C. — A new treatment for pancreatic cancer is being tested out in clinical trials in several states, and one North Carolina doctor called it “groundbreaking.” The trials are being…

A Lakewood Ranch retiree is one of the first patients in the country to receive an experimental treatment for pancreatic cancer through a trial offered at Sarasota Memorial Hospital. Vince…

Conference was Held January 15-17, 2021 Los Altos, CA, January 20, 2021 – RenovoRx, an innovator in targeted cancer therapy, today announced two research studies were presented at the 2021 ASCO…

During this Unprecedented Time with the COVID-19 Pandemic, Patients Continue to Elect Participation in this Important Trial Los Altos, CA, December 2, 2020 – RenovoRx, an innovator in targeted cancer…

Last year, a 74-year old woman was diagnosed with inoperable pancreatic cancer. Her family turned to Miami Cancer Institute in their search for treatment options. Since her diagnosis, she became part of the TIGeR-PaC…

Silicon Valley Company Created Innovative Trans-Arterial Micro-Perfusion (TAMP™) for Targeted Delivery of Chemotherapy to Treat Solid Tumors Los Altos, CA, September 15, 2020 – RenovoRx, an innovator in targeted cancer…

TIGeR-PaC — a Phase III Clinical Trial Continues Enrolling Pancreatic Cancer Patients in the U.S. and Europe Los Altos, CA, June 9, 2020 – RenovoRx, an innovator in targeted cancer…

TIGeR-PaC — a Phase III Clinical Trial Continues Enrolling Pancreatic Cancer Patients in U.S. and Europe Los Altos, CA, June 2, 2020 – RenovoRx, an innovator in targeted cancer therapy,…

TIGeR-PaC Phase III trial reaches first patient in Europe, with overall enrollment exceeding 20 percent worldwide Los Altos, Calif., Boston, Durham, N.C.– Jan. 13, 2020 – RenovoRx, Inc., an innovator in…